Objectives: To compare the effects of intranasal dexmedetomidine (DEX) and DEX-ketamine (KET) on hemodynamics and sedation quality in children with congenital heart disease.
Design: A randomized controlled, double-blind, prospective trial.
Setting: A tertiary care teaching hospital.